Certara, Inc.

Certara, Inc.

Certara, Inc.

Overview
Date Founded

2017

Headquarters

100 Overlook Center, Suite 101, Princeton, NJ, 08540, USA

Type of Company

Public

Employees (Worldwide)

300

Industries

Computer Software

Company Description

Certara, Inc. engages in the provision of software and technology enables services for drug developers. It offers cell and gene therapy, clinical pharmacology, complex biologics, decision analytics and modeling, drug development and regulatory strategy, and model-based analysis services. The company was founded on June 27, 2017 and is headquartered in Princeton, NJ.

Executives & Employees

Director & Chief Executive Officer

Chief Financial Officer & Principal Accounting Officer

General Counsel

Chief Strategy & Marketing Officer

Chief Scientific Officer

Chief Growth Officer

Chief Innovation Officer

President, Software

Senior Vice President, Corporate Strategy & Development

President, Simcyp

Board of Directors

Former Chief Executive Officer at Avon Products, Inc.

Director & Chief Executive Officer at Certara, Inc.

Senior Partner Healthcare Team at Arsenal Capital Management LP

Chairman at CRC Press LLC

Former Chief Executive Officer at ANSYS, Inc.

Chief Financial Officer, Organon at Merck & Co., Inc.

Partner at EQT Partners AB

Director-Private Equity at EQT Partners, Inc.

Paths to Certara, Inc.
Potential Connections via
Relationship Science
You
Certara, Inc.
Owners & Shareholders
Details Hidden

Sampension’s investment philosophy is based on the need to meet pension obligations in the long-term and to generate additional returns. The core element of the firm's investment strategy is diversification of risk through asset allocation.

Details Hidden

Howard Hughes Medical Institute's Investment Department's long-term investment objective is to maintain the inflation-adjusted value of investment returns, consistent with their research and grant program plans. While the returns needed to accomplish these purposes may not be achieved every year, it is anticipated that over time the constant dollar value of the endowment will be preserved, enabling program commitments to be continued, protected against the effects of inflation. Their endowment is managed under the direction of the Vice President and Chief Investment Officer with approximately 48% being managed in-house and the remainder managed by outside organizations.

Recent Transactions
Details Hidden

Certara, Inc. issued USD Common Stock

Details Hidden

Certara USA, Inc., Certara, Inc. purchase Analytica Laser

Insider Transactions
Details Hidden
Transaction Advisors

Advised onCertara, Inc. issued USD Common Stock

Underwriter

Advised onCertara, Inc. issued USD Common Stock

Underwriter

Advised onCertara, Inc. issued USD Common Stock

Attorney

Advised onCertara, Inc. issued USD Common Stock

Associate

Advised onCertara, Inc. issued USD Common Stock

Legal Advisor

Advised onCertara, Inc. issued USD Common Stock

Clients

Government of China operates executive offices. It offers information and services for its country. It provides services for travel, business, studies, work, immigrating, marriage, adoptions, and other country related issues. It handles all the different government agencies of the country, including office of the president, central government, and local government. Its website offers information guides about the country. It is located in Beijing, China.

Merck & Co., Inc. , d.b.a. Merck Sharp & Dohme, MSD outside the United States and Canada, is an American pharmaceutical company and is one of the largest pharmaceutical companies in the world.

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas, such as immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular & metabolic diseases. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular & neurovascular, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Key Stats and Financials As of 2020
Market Capitalization
$4.02B
Total Enterprise Value
$5.18B
Earnings Per Share
$-0.32
Revenue
$244M
Net Profit
$-49.4M
Total Debt
$299M
Total Equity
$822M
EBITDA
$18.3M
EBITDAMargin
7.53%
Enterprise Value / Sales
21.29x
Enterprise Value EBITDAOperating
282.8x
TEVNet Income
-104.96x
Debt TEV
0.06x
Competitors
Schrödinger, Inc. Computer Software - New York, NY

Schrödinger, Inc. engages in the provision of chemical simulation software solutions to pharmaceutical industry. It operates through the Software and Drug Discovery business segments. The Software segment sells software to transform drug discovery across the life sciences industry and to customers in materials science industries. The Drug Discovery segment offers diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have advanced to various stages of discovery and development. The company was founded by Richard A. Friesner, William A. Goddard, III and Murco Ringnalda in 1990 and is headquartered in New York, NY.

Icon Plc Pharmaceuticals - Dublin, Ireland

ICON plc operates as a clinical research organization, which engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical device industries. It specializes in the strategic development, management and analysis of programs that support clinical development. The company was founded by John Climax and Ronan Lambe in June 1990 and is headquartered in Dublin, Ireland.

Simulations Plus, Inc. Computer Software - Lancaster, California

Simulations Plus, Inc. provides modeling and simulation software and consulting services supporting drug discovery, development research, and regulatory submissions. It designs and develops pharmaceutical simulation software to promote cost-effective solutions to a number of problems in pharmaceutical research and in the education of pharmacy and medical students. The company was founded by Walter S. Woltosz and Virginia E. Woltosz on July 17, 1996 and is headquartered in Lancaster, CA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Certara, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Certara, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Certara, Inc..